Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

Thumbnail

Sanofi to acquire Provention Bio for $2.9B

Provention Bio's TZIELD is the first and only therapy to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D. 

 

Thumbnail

Pfizer to acquire Seagen for $43B

“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

One of the nation’s largest mobile imaging providers gets even bigger with latest acquisition

West Fargo, North Dakota-headquartered DMS Health Technologies is acquiring the assets of Advanced Imaging Management, bolstering its MRI and ultrasound offerings.  

Thumbnail

UnityPoint Health to merge with Presbyterian Healthcare Services

Both organizations signed a letter of intent to merge in a deal where both would keep their brands and continue to deliver care locally.

MercyOne completes acquisition of Genesis

The deal was first announced in September 2022, and with its closure, all interests and operations of Genesis become part of MercyOne.

Thumbnail

ProMedica sells hospice and home care business to Gentiva for $710M

The deal is expected to close in the second quarter of 2023.

Pfizer in talks to acquire Seagen in deal worth more than $30B

Pharmaceutical giant Pfizer is reportedly in talks to acquire Seagen, a biotechnology company focused on developing cancer therapies.

Tim Attebery, DSc, MBA, the CEO of Cardiovascular Associates of America and former CEO of the American College of Cardiology (ACC)

Q&A: Tim Attebery on why private equity-backed management companies are investing in cardiology

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology.